Molecular dynamics simulations of the structure of aldose reductase complexed with the inhibitor tolrestat

被引:11
作者
Rastelli, G [1 ]
Costantino, L [1 ]
机构
[1] Dipartimento Sci Farmaceut, I-41100 Modena, Italy
关键词
D O I
10.1016/S0960-894X(98)00083-3
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
This study reports a molecular dynamics (MD) investigation on the structure of aldose reductase (ALR2) complexed with the potent inhibitor tolrestat. The simulations predict four different orientations of tolrestat into the ALR2 binding site; these orientations have in common a strong interaction of the anionic carboxylate with Tyr48, His110, Trp111 and NADP(+), but completely differ for the orientation of the aromatic portion of the inhibitor. Interestingly, the orientation in which tolrestat gives the most attractive interaction energy with the enzyme is in full accord with the x-ray crystal structure of the complex that has been reported in the literature after this work was completed. in addition, the suggestion of more than one orientation of tolrestat during MD is in agreement with recent electrospray mass spectrometry experiments on the ALR2-tolrestat complex. (C) 1998 Elsevier Science Ltd. All rights reserved.
引用
收藏
页码:641 / 646
页数:6
相关论文
共 10 条
[1]  
BORHANI DW, 1992, J BIOL CHEM, V267, P24841
[2]   Synthesis, activity, and molecular modeling of a new series of tricyclic pyridazinones as selective aldose reductase inhibitors [J].
Costantino, L ;
Rastelli, G ;
Vescovini, K ;
Cignarella, G ;
Vianello, P ;
DelCorso, A ;
Cappiello, M ;
Mura, U ;
Barlocco, D .
JOURNAL OF MEDICINAL CHEMISTRY, 1996, 39 (22) :4396-4405
[3]  
COSTANTINO L, 1997, EXPERT OPIN THER PAT, V7, P1
[4]   Study of non-covalent enzyme-inhibitor complexes of aldose reductase by electrospray mass spectrometry [J].
Potier, N ;
Barth, P ;
Tritsch, D ;
Biellmann, JF ;
VanDorsselaer, A .
EUROPEAN JOURNAL OF BIOCHEMISTRY, 1997, 243 (1-2) :274-282
[5]   Structure-based design of an inhibitor modeled at the substrate active site of aldose reductase [J].
Rastelli, G ;
Vianello, P ;
Barlocco, D ;
Costantino, L ;
DelCorso, A ;
Mura, U .
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 1997, 7 (14) :1897-1902
[6]   NOVEL NADPH-BINDING DOMAIN REVEALED BY THE CRYSTAL-STRUCTURE OF ALDOSE REDUCTASE [J].
RONDEAU, JM ;
TETEFAVIER, F ;
PODJARNY, A ;
REYMANN, JM ;
BARTH, P ;
BIELLMANN, JF ;
MORAS, D .
NATURE, 1992, 355 (6359) :469-472
[7]   ALDOSE REDUCTASE INHIBITORS AND THEIR POTENTIAL FOR THE TREATMENT OF DIABETIC COMPLICATIONS [J].
TOMLINSON, DR ;
STEVENS, EJ ;
DIEMEL, LT .
TRENDS IN PHARMACOLOGICAL SCIENCES, 1994, 15 (08) :293-297
[8]   A 'specificity' pocket inferred from the crystal structures of the complexes of aldose reductase with the pharmaceutically important inhibitors tolrestat and sorbinil [J].
Urzhumtsev, A ;
TeteFavier, F ;
Mitschler, A ;
Barbanton, J ;
Barth, P ;
Urzhumtseva, L ;
Biellmann, JF ;
Podjarny, AD ;
Moras, D .
STRUCTURE, 1997, 5 (05) :601-612
[9]   AN UNLIKELY SUGAR SUBSTRATE SITE IN THE 1.65 ANGSTROM STRUCTURE OF THE HUMAN ALDOSE REDUCTASE HOLOENZYME IMPLICATED IN DIABETIC COMPLICATIONS [J].
WILSON, DK ;
BOHREN, KM ;
GABBAY, KH ;
QUIOCHO, FA .
SCIENCE, 1992, 257 (5066) :81-84
[10]   REFINED 1.8-ANGSTROM STRUCTURE OF HUMAN ALDOSE REDUCTASE COMPLEXED WITH THE POTENT INHIBITOR ZOPOLRESTAT [J].
WILSON, DK ;
TARLE, I ;
PETRASH, JM ;
QUIOCHO, FA .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1993, 90 (21) :9847-9851